Review



human mirna microarray platform (8 x 60 k, release 21.0  (Agilent technologies)


Bioz Verified Symbol Agilent technologies is a verified supplier
Bioz Manufacturer Symbol Agilent technologies manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Agilent technologies human mirna microarray platform (8 x 60 k, release 21.0
    Human Mirna Microarray Platform (8 X 60 K, Release 21.0, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mirna+microarray+platform/pm31704611-70-10-20
    Average 90 stars, based on 1 article reviews
    human mirna microarray platform (8 x 60 k, release 21.0 - by Bioz Stars, 2026-11
    90/100 stars

    Images

    Related Articles

    Microarray:

    Article Title: Perspectives on miRNAs as Epigenetic Markers in Osteoporosis and Bone Fracture Risk: A Step Forward in Personalized Diagnosis
    Article Snippet: ( ) , Discovery cohort: 25 PM women with OP and 23 PM Chinese women with osteopenia (age 59-70 years)Validation cohort: 24 PM Chinese women with normal, 32 with OP and 30 with osteopenia range BMD (age 59-70 years) , Whole blood , Blood samples lysed using RBC lysis solution and centrifuged for 10 min at 450g , Discovery: Agilent Human miRNA microarray followed by SYBR Green RT-qPCR Validation: SYBR Green RT-qPCR , Discovery cohort: comprehensive miRNA expression analysis (Microarray); miR-130b-3p, miR-151a-3p, miR-151b, miR-194-5p, miR-590-5p, and miR-660-5p (RT-qPCR) Validation cohort: miR-194-5p , snRNU6 , ↑ miR-130b-3p, miR-151a-3p, miR-151b, miR-194-5p, and miR-590-5p in OP vs. osteopenia (Discovery cohort)↑ miR-194-5p in OP and osteopenia vs. control (Validation cohort) , / , / , Small sample size; no evaluation of the target genes; no ROC analysis. .. ( ) , 155 PM Chinese women with PM OP (n = 81, age 51-62 years) or healthy (n = 74, age 40-46 years) , Cell-free serum and BM-MSCs , / , Screening: Agilent Human miRNA Microarray Validation: TaqMan RT-qPCR , Screening: 851 miRNAs Validation: miR-27a , snRNU6 , ↓ miR-27a in OP vs. control , Mef2c (predicted for miR-27a using TargetScan and PicTar database and validated by in vitro studies) , / , The mean age of OP and healthy women is significantly different; no information about the stem-loop arm of miRNA origin; no ROC analysis. .. ( ) , 74 PM women (age 55-65 years): 57 controls and 17 OP based on femoral neck/lumbar spine/total hip T-score ≤–2.5 SD , Cell-free plasma , Blood samples collected in EDTA tubes, centrifuged at 2800 rpm and 4°C for 10 min, then further centrifuged at 9600g and 4°C for 15 min. Plasma samples stored at -80°C , SYBR Green RT-qPCR , miR-7d-5p, miR-7e-5p, miR-30 d-5p, miR-30e-5p, miR-126-3p, miR-148a-3p, miR-199a-3p, miR-423-5p, and miR-574-5p , Combination of let-7a-5p and miR-16-5p as identified by Normfinder , ↑ miR-148a-3p in OP vs. control , / , / , Small sample size of the control group; no evaluation of the target genes; no ROC analysis.

    Article Title: Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes
    Article Snippet: .. Serum samples were collected from 12 primary OA patients, and 12 healthy individuals were screened using the Agilent Human miRNA Microarray platform interrogating 2549 miRNAs. ..

    Article Title: IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma
    Article Snippet: The mRNA levels of IL-10 , IL-10Rα , and IL-10Rβ were normalized to endogenous β- actin (Applied Biosystems). .. miRNA microarray experiments were performed using a human miRNA microarray platform (Agilent Sanger miRBase, release 10.1) with 723 human and 76 human viral miRNAs represented. .. Agilent Feature Extraction Software was used for background subtraction.

    Article Title: miR-205 inhibits the development of hypertrophic scars by targeting THBS1
    Article Snippet: .. High-throughput Agilent human miRNA microarray was used to analyze and compare the miRNA molecules differentially expressed in 30 pairs of hypertrophic scar and normal skin tissues. ..

    Article Title: Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening.
    Article Snippet: .. The intensity of each hybridization signal was detected using the Human miRNA Microarray platform (8 x 60 K, Release 21.0; Agilent Technologies, Santa Clara, CA, USA) and Microarray Scanner (Agilent Technologies), which encompassed 2568 human miRNAs. ..

    Biomarker Discovery:

    Article Title: Perspectives on miRNAs as Epigenetic Markers in Osteoporosis and Bone Fracture Risk: A Step Forward in Personalized Diagnosis
    Article Snippet: ( ) , Discovery cohort: 25 PM women with OP and 23 PM Chinese women with osteopenia (age 59-70 years)Validation cohort: 24 PM Chinese women with normal, 32 with OP and 30 with osteopenia range BMD (age 59-70 years) , Whole blood , Blood samples lysed using RBC lysis solution and centrifuged for 10 min at 450g , Discovery: Agilent Human miRNA microarray followed by SYBR Green RT-qPCR Validation: SYBR Green RT-qPCR , Discovery cohort: comprehensive miRNA expression analysis (Microarray); miR-130b-3p, miR-151a-3p, miR-151b, miR-194-5p, miR-590-5p, and miR-660-5p (RT-qPCR) Validation cohort: miR-194-5p , snRNU6 , ↑ miR-130b-3p, miR-151a-3p, miR-151b, miR-194-5p, and miR-590-5p in OP vs. osteopenia (Discovery cohort)↑ miR-194-5p in OP and osteopenia vs. control (Validation cohort) , / , / , Small sample size; no evaluation of the target genes; no ROC analysis. .. ( ) , 155 PM Chinese women with PM OP (n = 81, age 51-62 years) or healthy (n = 74, age 40-46 years) , Cell-free serum and BM-MSCs , / , Screening: Agilent Human miRNA Microarray Validation: TaqMan RT-qPCR , Screening: 851 miRNAs Validation: miR-27a , snRNU6 , ↓ miR-27a in OP vs. control , Mef2c (predicted for miR-27a using TargetScan and PicTar database and validated by in vitro studies) , / , The mean age of OP and healthy women is significantly different; no information about the stem-loop arm of miRNA origin; no ROC analysis. .. ( ) , 74 PM women (age 55-65 years): 57 controls and 17 OP based on femoral neck/lumbar spine/total hip T-score ≤–2.5 SD , Cell-free plasma , Blood samples collected in EDTA tubes, centrifuged at 2800 rpm and 4°C for 10 min, then further centrifuged at 9600g and 4°C for 15 min. Plasma samples stored at -80°C , SYBR Green RT-qPCR , miR-7d-5p, miR-7e-5p, miR-30 d-5p, miR-30e-5p, miR-126-3p, miR-148a-3p, miR-199a-3p, miR-423-5p, and miR-574-5p , Combination of let-7a-5p and miR-16-5p as identified by Normfinder , ↑ miR-148a-3p in OP vs. control , / , / , Small sample size of the control group; no evaluation of the target genes; no ROC analysis.

    Quantitative RT-PCR:

    Article Title: Perspectives on miRNAs as Epigenetic Markers in Osteoporosis and Bone Fracture Risk: A Step Forward in Personalized Diagnosis
    Article Snippet: ( ) , Discovery cohort: 25 PM women with OP and 23 PM Chinese women with osteopenia (age 59-70 years)Validation cohort: 24 PM Chinese women with normal, 32 with OP and 30 with osteopenia range BMD (age 59-70 years) , Whole blood , Blood samples lysed using RBC lysis solution and centrifuged for 10 min at 450g , Discovery: Agilent Human miRNA microarray followed by SYBR Green RT-qPCR Validation: SYBR Green RT-qPCR , Discovery cohort: comprehensive miRNA expression analysis (Microarray); miR-130b-3p, miR-151a-3p, miR-151b, miR-194-5p, miR-590-5p, and miR-660-5p (RT-qPCR) Validation cohort: miR-194-5p , snRNU6 , ↑ miR-130b-3p, miR-151a-3p, miR-151b, miR-194-5p, and miR-590-5p in OP vs. osteopenia (Discovery cohort)↑ miR-194-5p in OP and osteopenia vs. control (Validation cohort) , / , / , Small sample size; no evaluation of the target genes; no ROC analysis. .. ( ) , 155 PM Chinese women with PM OP (n = 81, age 51-62 years) or healthy (n = 74, age 40-46 years) , Cell-free serum and BM-MSCs , / , Screening: Agilent Human miRNA Microarray Validation: TaqMan RT-qPCR , Screening: 851 miRNAs Validation: miR-27a , snRNU6 , ↓ miR-27a in OP vs. control , Mef2c (predicted for miR-27a using TargetScan and PicTar database and validated by in vitro studies) , / , The mean age of OP and healthy women is significantly different; no information about the stem-loop arm of miRNA origin; no ROC analysis. .. ( ) , 74 PM women (age 55-65 years): 57 controls and 17 OP based on femoral neck/lumbar spine/total hip T-score ≤–2.5 SD , Cell-free plasma , Blood samples collected in EDTA tubes, centrifuged at 2800 rpm and 4°C for 10 min, then further centrifuged at 9600g and 4°C for 15 min. Plasma samples stored at -80°C , SYBR Green RT-qPCR , miR-7d-5p, miR-7e-5p, miR-30 d-5p, miR-30e-5p, miR-126-3p, miR-148a-3p, miR-199a-3p, miR-423-5p, and miR-574-5p , Combination of let-7a-5p and miR-16-5p as identified by Normfinder , ↑ miR-148a-3p in OP vs. control , / , / , Small sample size of the control group; no evaluation of the target genes; no ROC analysis.

    Control:

    Article Title: Perspectives on miRNAs as Epigenetic Markers in Osteoporosis and Bone Fracture Risk: A Step Forward in Personalized Diagnosis
    Article Snippet: ( ) , Discovery cohort: 25 PM women with OP and 23 PM Chinese women with osteopenia (age 59-70 years)Validation cohort: 24 PM Chinese women with normal, 32 with OP and 30 with osteopenia range BMD (age 59-70 years) , Whole blood , Blood samples lysed using RBC lysis solution and centrifuged for 10 min at 450g , Discovery: Agilent Human miRNA microarray followed by SYBR Green RT-qPCR Validation: SYBR Green RT-qPCR , Discovery cohort: comprehensive miRNA expression analysis (Microarray); miR-130b-3p, miR-151a-3p, miR-151b, miR-194-5p, miR-590-5p, and miR-660-5p (RT-qPCR) Validation cohort: miR-194-5p , snRNU6 , ↑ miR-130b-3p, miR-151a-3p, miR-151b, miR-194-5p, and miR-590-5p in OP vs. osteopenia (Discovery cohort)↑ miR-194-5p in OP and osteopenia vs. control (Validation cohort) , / , / , Small sample size; no evaluation of the target genes; no ROC analysis. .. ( ) , 155 PM Chinese women with PM OP (n = 81, age 51-62 years) or healthy (n = 74, age 40-46 years) , Cell-free serum and BM-MSCs , / , Screening: Agilent Human miRNA Microarray Validation: TaqMan RT-qPCR , Screening: 851 miRNAs Validation: miR-27a , snRNU6 , ↓ miR-27a in OP vs. control , Mef2c (predicted for miR-27a using TargetScan and PicTar database and validated by in vitro studies) , / , The mean age of OP and healthy women is significantly different; no information about the stem-loop arm of miRNA origin; no ROC analysis. .. ( ) , 74 PM women (age 55-65 years): 57 controls and 17 OP based on femoral neck/lumbar spine/total hip T-score ≤–2.5 SD , Cell-free plasma , Blood samples collected in EDTA tubes, centrifuged at 2800 rpm and 4°C for 10 min, then further centrifuged at 9600g and 4°C for 15 min. Plasma samples stored at -80°C , SYBR Green RT-qPCR , miR-7d-5p, miR-7e-5p, miR-30 d-5p, miR-30e-5p, miR-126-3p, miR-148a-3p, miR-199a-3p, miR-423-5p, and miR-574-5p , Combination of let-7a-5p and miR-16-5p as identified by Normfinder , ↑ miR-148a-3p in OP vs. control , / , / , Small sample size of the control group; no evaluation of the target genes; no ROC analysis.

    In Vitro:

    Article Title: Perspectives on miRNAs as Epigenetic Markers in Osteoporosis and Bone Fracture Risk: A Step Forward in Personalized Diagnosis
    Article Snippet: ( ) , Discovery cohort: 25 PM women with OP and 23 PM Chinese women with osteopenia (age 59-70 years)Validation cohort: 24 PM Chinese women with normal, 32 with OP and 30 with osteopenia range BMD (age 59-70 years) , Whole blood , Blood samples lysed using RBC lysis solution and centrifuged for 10 min at 450g , Discovery: Agilent Human miRNA microarray followed by SYBR Green RT-qPCR Validation: SYBR Green RT-qPCR , Discovery cohort: comprehensive miRNA expression analysis (Microarray); miR-130b-3p, miR-151a-3p, miR-151b, miR-194-5p, miR-590-5p, and miR-660-5p (RT-qPCR) Validation cohort: miR-194-5p , snRNU6 , ↑ miR-130b-3p, miR-151a-3p, miR-151b, miR-194-5p, and miR-590-5p in OP vs. osteopenia (Discovery cohort)↑ miR-194-5p in OP and osteopenia vs. control (Validation cohort) , / , / , Small sample size; no evaluation of the target genes; no ROC analysis. .. ( ) , 155 PM Chinese women with PM OP (n = 81, age 51-62 years) or healthy (n = 74, age 40-46 years) , Cell-free serum and BM-MSCs , / , Screening: Agilent Human miRNA Microarray Validation: TaqMan RT-qPCR , Screening: 851 miRNAs Validation: miR-27a , snRNU6 , ↓ miR-27a in OP vs. control , Mef2c (predicted for miR-27a using TargetScan and PicTar database and validated by in vitro studies) , / , The mean age of OP and healthy women is significantly different; no information about the stem-loop arm of miRNA origin; no ROC analysis. .. ( ) , 74 PM women (age 55-65 years): 57 controls and 17 OP based on femoral neck/lumbar spine/total hip T-score ≤–2.5 SD , Cell-free plasma , Blood samples collected in EDTA tubes, centrifuged at 2800 rpm and 4°C for 10 min, then further centrifuged at 9600g and 4°C for 15 min. Plasma samples stored at -80°C , SYBR Green RT-qPCR , miR-7d-5p, miR-7e-5p, miR-30 d-5p, miR-30e-5p, miR-126-3p, miR-148a-3p, miR-199a-3p, miR-423-5p, and miR-574-5p , Combination of let-7a-5p and miR-16-5p as identified by Normfinder , ↑ miR-148a-3p in OP vs. control , / , / , Small sample size of the control group; no evaluation of the target genes; no ROC analysis.

    other:

    Article Title: MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab
    Article Snippet: The whole-genome expression data, Affymetrix raw data (.cel files), were normalized using the robust multichip average (RMA) algorithm from ‘oligo’ Bioconductor package in R version 3.0.1.

    Article Title: The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma
    Article Snippet: Total RNA was extracted from fresh tissues of eighteen cases of BL (six EBV-positive BLs and twelve EBV-negative BLs) using TRIZOL reagent (Invitrogen, CA).

    Hybridization:

    Article Title: Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening.
    Article Snippet: .. The intensity of each hybridization signal was detected using the Human miRNA Microarray platform (8 x 60 K, Release 21.0; Agilent Technologies, Santa Clara, CA, USA) and Microarray Scanner (Agilent Technologies), which encompassed 2568 human miRNAs. ..



    Similar Products

    90
    Agilent technologies human mirna microarray platform
    Human Mirna Microarray Platform, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mirna+microarray+platform/pm37995394-86-8-12
    Average 90 stars, based on 1 article reviews
    human mirna microarray platform - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Toray Industries 3d-gene human mirna v21_1.0.0 microarray platform
    3d Gene Human Mirna V21 1.0.0 Microarray Platform, supplied by Toray Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mirna+microarray+platform/3d+gene+scanner/pm37935712-342-7-11
    Average 90 stars, based on 1 article reviews
    3d-gene human mirna v21_1.0.0 microarray platform - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Agilent technologies -019118 human mirna microarray 2.0 platform
    Clinicopathological characteristics of TNBC patients in this study.
    019118 Human Mirna Microarray 2.0 Platform, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mirna+microarray+platform/pmc07392022-72-7-7
    Average 90 stars, based on 1 article reviews
    -019118 human mirna microarray 2.0 platform - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Agilent technologies human mirna microarray platform (version 3
    We confirmed the gene expression levels of miRNAs using real-time qPCR. We analyzed the expression of 7 miRNAs (hsa-miR-223, hsa-miR-365 hsa-miR-424, and hsa-miR-451, hsa-miR-144, hsa-miR-500 and hsa-miR-21*) selected from the <t>microarray</t> data by qPCR. The 2 −ΔΔCT method was used to normalize the relative gene expression data in the qPCR assay. U6 snRNA was set as the reference gene. The <t>miRNA</t> expression value in one subject with LTBI was normalized to 1. Statistical analysis was performed using the unpaired t-test. ** P <0.01, * P <0.05, NS: not significant.
    Human Mirna Microarray Platform (Version 3, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mirna+microarray+platform/pmc03189221-214-8-14
    Average 90 stars, based on 1 article reviews
    human mirna microarray platform (version 3 - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Agilent technologies 8 × 15 k human mirna-specific microarray platform
    We confirmed the gene expression levels of miRNAs using real-time qPCR. We analyzed the expression of 7 miRNAs (hsa-miR-223, hsa-miR-365 hsa-miR-424, and hsa-miR-451, hsa-miR-144, hsa-miR-500 and hsa-miR-21*) selected from the <t>microarray</t> data by qPCR. The 2 −ΔΔCT method was used to normalize the relative gene expression data in the qPCR assay. U6 snRNA was set as the reference gene. The <t>miRNA</t> expression value in one subject with LTBI was normalized to 1. Statistical analysis was performed using the unpaired t-test. ** P <0.01, * P <0.05, NS: not significant.
    8 × 15 K Human Mirna Specific Microarray Platform, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mirna+microarray+platform/pmc03342161-117-18-13
    Average 90 stars, based on 1 article reviews
    8 × 15 k human mirna-specific microarray platform - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Agilent technologies 8 × 15 k human mirna-specific microarray v2 platform
    We confirmed the gene expression levels of miRNAs using real-time qPCR. We analyzed the expression of 7 miRNAs (hsa-miR-223, hsa-miR-365 hsa-miR-424, and hsa-miR-451, hsa-miR-144, hsa-miR-500 and hsa-miR-21*) selected from the <t>microarray</t> data by qPCR. The 2 −ΔΔCT method was used to normalize the relative gene expression data in the qPCR assay. U6 snRNA was set as the reference gene. The <t>miRNA</t> expression value in one subject with LTBI was normalized to 1. Statistical analysis was performed using the unpaired t-test. ** P <0.01, * P <0.05, NS: not significant.
    8 × 15 K Human Mirna Specific Microarray V2 Platform, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mirna+microarray+platform/pmc03938445-146-30-25
    Average 90 stars, based on 1 article reviews
    8 × 15 k human mirna-specific microarray v2 platform - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Agilent technologies human mirna microarray rel12.0 platform
    We confirmed the gene expression levels of miRNAs using real-time qPCR. We analyzed the expression of 7 miRNAs (hsa-miR-223, hsa-miR-365 hsa-miR-424, and hsa-miR-451, hsa-miR-144, hsa-miR-500 and hsa-miR-21*) selected from the <t>microarray</t> data by qPCR. The 2 −ΔΔCT method was used to normalize the relative gene expression data in the qPCR assay. U6 snRNA was set as the reference gene. The <t>miRNA</t> expression value in one subject with LTBI was normalized to 1. Statistical analysis was performed using the unpaired t-test. ** P <0.01, * P <0.05, NS: not significant.
    Human Mirna Microarray Rel12.0 Platform, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mirna+microarray+platform/pmc07802940-62-9-10
    Average 90 stars, based on 1 article reviews
    human mirna microarray rel12.0 platform - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Agilent technologies human mirna microarray platform (8 x 60 k, release 21.0
    We confirmed the gene expression levels of miRNAs using real-time qPCR. We analyzed the expression of 7 miRNAs (hsa-miR-223, hsa-miR-365 hsa-miR-424, and hsa-miR-451, hsa-miR-144, hsa-miR-500 and hsa-miR-21*) selected from the <t>microarray</t> data by qPCR. The 2 −ΔΔCT method was used to normalize the relative gene expression data in the qPCR assay. U6 snRNA was set as the reference gene. The <t>miRNA</t> expression value in one subject with LTBI was normalized to 1. Statistical analysis was performed using the unpaired t-test. ** P <0.01, * P <0.05, NS: not significant.
    Human Mirna Microarray Platform (8 X 60 K, Release 21.0, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+mirna+microarray+platform/pm31704611-70-10-20
    Average 90 stars, based on 1 article reviews
    human mirna microarray platform (8 x 60 k, release 21.0 - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    Clinicopathological characteristics of TNBC patients in this study.

    Journal: Theranostics

    Article Title: A panel of eight microRNAs is a good predictive parameter for triple-negative breast cancer relapse

    doi: 10.7150/thno.46142

    Figure Lengend Snippet: Clinicopathological characteristics of TNBC patients in this study.

    Article Snippet: The GEOD-40525 dataset was based on an Agilent-019118 Human miRNA Microarray 2.0 platform (n=8).

    Techniques: Preserving, Sequencing, Microarray

    We confirmed the gene expression levels of miRNAs using real-time qPCR. We analyzed the expression of 7 miRNAs (hsa-miR-223, hsa-miR-365 hsa-miR-424, and hsa-miR-451, hsa-miR-144, hsa-miR-500 and hsa-miR-21*) selected from the microarray data by qPCR. The 2 −ΔΔCT method was used to normalize the relative gene expression data in the qPCR assay. U6 snRNA was set as the reference gene. The miRNA expression value in one subject with LTBI was normalized to 1. Statistical analysis was performed using the unpaired t-test. ** P <0.01, * P <0.05, NS: not significant.

    Journal: PLoS ONE

    Article Title: Comparative miRNA Expression Profiles in Individuals with Latent and Active Tuberculosis

    doi: 10.1371/journal.pone.0025832

    Figure Lengend Snippet: We confirmed the gene expression levels of miRNAs using real-time qPCR. We analyzed the expression of 7 miRNAs (hsa-miR-223, hsa-miR-365 hsa-miR-424, and hsa-miR-451, hsa-miR-144, hsa-miR-500 and hsa-miR-21*) selected from the microarray data by qPCR. The 2 −ΔΔCT method was used to normalize the relative gene expression data in the qPCR assay. U6 snRNA was set as the reference gene. The miRNA expression value in one subject with LTBI was normalized to 1. Statistical analysis was performed using the unpaired t-test. ** P <0.01, * P <0.05, NS: not significant.

    Article Snippet: MiRNA microarray assays were performed using the Agilent Human miRNA microarray platform (version 3, Agilent Technologies) at Shanghai Biochip Co., Ltd. (Shanghai, China).

    Techniques: Expressing, Microarray